Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical and Experimental Pharmacology and Physiology"
DOI: 10.1111/1440-1681.13595
Abstract: Propofol, a widely used short‐acting intravenous sedative agent, has gradually gained attention due to the tumour‐suppressing role and non‐anaesthetic effect. Dysfunction of metabolic reprogramming has been recognised as a well‐documented factor for tumour progression. The…
read more here.
Keywords:
gastric cancer;
cell proliferation;
mediated polyol;
polyol pathway ... See more keywords